• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性肾性尿崩症患者及携带者尿液中环状单磷酸腺苷的排泄情况。

Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.

作者信息

Uttley W S, Atkinson B, Adams A, Shirling D

出版信息

J Inherit Metab Dis. 1978;1(2):75-7. doi: 10.1007/BF01801849.

DOI:10.1007/BF01801849
PMID:229343
Abstract

Urinary excretion of cyclic adenosine monophosphate (cAMP) is assessed in response to pitressin stimulation in three patients with nephrogenic diabetes insipidus, four carriers and seven controls. There is no significant difference in cAMP excretion between these groups when corrected for surface area, nor is there any significant increase in excretion after pitressin stimulation. There is very close correlation between urinary cAMP and both urinary concentration and urinary creatinine excretion. Urinary cAMP after pitressin stimulation does not discriminate between carriers of nephrogenic diabetes insipidus and control subjects.

摘要

对三名肾性尿崩症患者、四名携带者和七名对照者,评估了抗利尿激素刺激后环磷酸腺苷(cAMP)的尿排泄情况。校正体表面积后,这些组之间的cAMP排泄无显著差异,抗利尿激素刺激后排泄也无显著增加。尿cAMP与尿浓缩及尿肌酐排泄之间存在非常密切的相关性。抗利尿激素刺激后的尿cAMP无法区分肾性尿崩症携带者和对照者。

相似文献

1
Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.先天性肾性尿崩症患者及携带者尿液中环状单磷酸腺苷的排泄情况。
J Inherit Metab Dis. 1978;1(2):75-7. doi: 10.1007/BF01801849.
2
Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.尿崩症(DI)中抗利尿激素对尿腺苷 3',5'-单磷酸(cAMP)的反应:先天性 1 型和 2 型肾性尿崩症与血管加压素敏感性尿崩症的比较
Acta Endocrinol (Copenh). 1985 Apr;108(4):485-90. doi: 10.1530/acta.0.1080485.
3
Congenital nephrogenic diabetes insipidus in a baby girl.一名女婴患先天性肾性尿崩症。
Arch Dis Child. 1978 Nov;53(11):906-8. doi: 10.1136/adc.53.11.unknown.
4
The mechanism of urinary concentration in nephrogenic diabetes insipidus.肾性尿崩症中尿液浓缩的机制。
Pediatr Res. 1977 Jan;11(1 Pt 1):33-6.
5
Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
J Pediatr. 1984 Apr;104(4):593-5. doi: 10.1016/s0022-3476(84)80556-9.
6
Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
Scand J Clin Lab Invest. 1974 Oct;34(2):177-84.
7
1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
Clin Pharmacol Ther. 1981 Jun;29(6):793-7. doi: 10.1038/clpt.1981.113.
8
[Congenital nephrogenic diabetes insipidus].[先天性肾性尿崩症]
Rev Prat. 1994 May 1;44(9):1169-72.
9
Basal and hormone-induced urinary cyclic AMP in children with renal disorders.
Acta Paediatr Scand. 1976 Nov;65(6):739-45. doi: 10.1111/j.1651-2227.1976.tb18012.x.
10
Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.先天性肾性尿崩症中V1-血管加压素受体完整的证据。
Eur J Pediatr. 1992 May;151(5):381-3. doi: 10.1007/BF02113263.

本文引用的文献

1
The similarity of effects of vasopressin, adenosine-3',5'-phosphate (cyclic AMP) and theophylline on the toad bladder.血管加压素、腺苷 - 3',5'-磷酸(环磷酸腺苷)和茶碱对蟾蜍膀胱作用的相似性。
J Clin Invest. 1962 Apr;41(4):702-9. doi: 10.1172/JCI104528.
2
The carrier state in nephrogenic diabetes insipidus.肾性尿崩症的携带者状态。
Lancet. 1956 Nov 24;271(6952):1069-73. doi: 10.1016/s0140-6736(56)90206-9.
3
Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.肾腺苷酸环化酶:甲状旁腺激素和血管加压素的解剖学上分开的作用位点。
Science. 1968 Feb 2;159(3814):545-7. doi: 10.1126/science.159.3814.545.
4
Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.人体中血浆3',5'-单磷酸腺苷和3',5'-单磷酸鸟苷的动力学参数及肾清除率
J Clin Invest. 1970 Dec;49(12):2222-36. doi: 10.1172/JCI106441.
5
The role of adenosine 3',5'-phosphate in the action of antidiuretic hormone.3',5'-磷酸腺苷在抗利尿激素作用中的角色。
Am J Med. 1967 May;42(5):757-68. doi: 10.1016/0002-9343(67)90093-9.
6
Failure to detect the carrier in congenital nephrogenic diabetes insipidus.先天性肾性尿崩症中未能检测出携带者。
Arch Dis Child. 1972 Feb;47(251):137-9. doi: 10.1136/adc.47.251.137.
7
Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
Scand J Clin Lab Invest. 1974 Oct;34(2):177-84.
8
Demonstration of a defect in the formation of adenosine 3',5'-monophosphate in vasopressin-resistant diabetes insipidus.抗血管升压素性尿崩症中3',5'-单磷酸腺苷形成缺陷的证明。
Pediatr Res. 1974 Apr;8(4):223-30. doi: 10.1203/00006450-197404000-00002.
9
Saturation assay for cyclic AMP using endogenous binding protein.使用内源性结合蛋白的环磷酸腺苷饱和度测定法。
Adv Cyclic Nucleotide Res. 1972;2:25-40.
10
Nephrogenic diabetes insipidus. Effects of 3,5, cyclic-adenosine monophosphate.肾性尿崩症。3,5-环磷酸腺苷的作用。
Arch Dis Child. 1972 Oct;47(255):794-7. doi: 10.1136/adc.47.255.794.